<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02983643</url>
  </required_header>
  <id_info>
    <org_study_id>IM.J-EC.04</org_study_id>
    <nct_id>NCT02983643</nct_id>
  </id_info>
  <brief_title>Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients</brief_title>
  <official_title>Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aix Marseille Universit√©</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Skeletal Muscle Index (SMI) and Visceral Adipose Ratio (VAR) assess body composition changes
      and disclose malnutrition risk effectively. The aims of the study are to assess prevalence of
      malnutrition in patients planned for SCT, to characterize changes in body composition (SMI,
      total adipose tissue and VAR) that occur in the peri transplantation phase, and to identify
      Waist Circumference (WC) cut off points associated with the metabolic syndrome (MetSyn) in
      patients with B and T cell Lymphoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a retrospective cohort study of patients having B and T cell lymphoma, who
      underwent SCT in the Bone Marrow Transplantation (BMT) unit at AUBMC. Consecutive patients
      having B and T lymphoma who underwent SCT at AUBMC will be identified by the research team
      and will be included as per the below inclusion and exclusion criteria. Starting from June
      2016, patients who meet the inclusion criteria will be included in the study up until June
      2006.

      The radiologist will access the AUBMC PACS system to review PET/CT scans of the identified
      patients. SMI, visceral, subcutaneous and intramuscular adipose tissues will be established
      by assessing at the level of L3.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sarcopenia Prevalence</measure>
    <time_frame>3 months post Stem Cell Transplantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Skeletal Muscle Index Changes</measure>
    <time_frame>3 months post Stem Cell Transplantation</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Hematopoietic Stem Cell Transplantation</condition>
  <condition>Malnutrition</condition>
  <condition>Metabolic Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients having B and T lymphoma who underwent SCT between January 2006 and
        June 2016 at AUBMC are identified by the research team and are included as per the below
        inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;16 years

          -  Patients having B and T cell lymphoma who have undergone SCT at AUBMC

        Exclusion Criteria:

          -  Patients with a missing pre-SCT PET/ CT scan

          -  Patients with 2 missing post SCT PET / CT scan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean El Cheikh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AUBMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean El Cheikh, MD</last_name>
    <phone>9611350000</phone>
    <phone_ext>7811</phone_ext>
    <email>je46@aub.edu.lb</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jana Jabbour, LD, MPH</last_name>
    <phone>9611759668</phone>
    <email>jj13@aub.edu.lb</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>American University of Beirut Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Jabbour, LD, MPH</last_name>
      <phone>+961759668</phone>
      <email>jj13@aub.edu.lb</email>
    </contact>
    <contact_backup>
      <last_name>Jean El Cheikh, MD</last_name>
      <phone>+961350000</phone>
      <phone_ext>7811</phone_ext>
      <email>je46@aub.edu.lb</email>
    </contact_backup>
    <investigator>
      <last_name>Jean El Cheikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jana Jabbour, LD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Batoul Manana, LD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charbel Saadeh, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ali Bazarbachi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Didier Blaise, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iman Abou Dalle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2016</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Skeletal Muscle Index</keyword>
  <keyword>Visceral Adipose Tissue</keyword>
  <keyword>Metabolic Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

